CBT · Cabot Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.71B | $3.99B | $3.93B | $4.32B | $3.41B | $2.61B |
| Cost of Revenue | $2.77B | $3.03B | $3.09B | $3.44B | $2.61B | $2.11B |
| Gross Profit | $940.00M | $960.00M | $839.00M | $885.00M | $799.00M | $500.00M |
| R&D | $59.00M | $63.00M | $57.00M | $55.00M | $56.00M | $57.00M |
| SG&A | $260.00M | $283.00M | $253.00M | $258.00M | $289.00M | $292.00M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $154.00M | $151.00M | $144.00M | $146.00M | $160.00M | $158.00M |
| Operating Income | $621.00M | $614.00M | $526.00M | $389.00M | $454.00M | $21.00M |
| Interest Expense | $76.00M | $81.00M | $90.00M | $56.00M | $49.00M | $53.00M |
| Income Tax | $196.00M | $111.00M | ($28.00M) | $102.00M | $123.00M | $191.00M |
| Net Income | $331.00M | $380.00M | $445.00M | $209.00M | $250.00M | ($238.00M) |
| EPS - Basic | $6.07 | $6.79 | $7.79 | $3.65 | $4.35 | ($4.21) |
| EPS - Diluted | $6.02 | $6.72 | $7.73 | $3.62 | $4.34 | ($4.21) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $258.00M | $223.00M | $238.00M | $206.00M | $168.00M | $151.00M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | $504.00M | $552.00M | $585.00M | $664.00M | $523.00M | $359.00M |
| Accounts Payable | $459.00M | $495.00M | $438.00M | $533.00M | $480.00M | $316.00M |
| Current Assets | $1.54B | $1.60B | $1.63B | $1.82B | $1.43B | $978.00M |
| Total Assets | $3.81B | $3.74B | $3.60B | $3.52B | $3.31B | $2.78B |
| Current Liabilities | $957.00M | $772.00M | $822.00M | $1.10B | $1.15B | $529.00M |
| Long-term Debt | $856.00M | $1.09B | $1.09B | $1.09B | $717.00M | $1.09B |
| Total Liabilities | - | - | - | - | - | - |
| Stockholders' Equity | $1.55B | $1.43B | $1.26B | $898.00M | $947.00M | $691.00M |
| Retained Earnings | $1.83B | $1.73B | $1.57B | $1.28B | $1.16B | $989.00M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $665.00M | $692.00M | $595.00M | $100.00M | $257.00M | $377.00M |
| Investing Cash Flow | ($298.00M) | ($235.00M) | ($214.00M) | ($118.00M) | ($186.00M) | ($288.00M) |
| Financing Cash Flow | ($336.00M) | ($415.00M) | ($403.00M) | $145.00M | ($60.00M) | ($132.00M) |
| CapEx | $274.00M | $241.00M | $244.00M | $211.00M | $195.00M | $200.00M |
| Free Cash Flow | $391.00M | $451.00M | $351.00M | ($111.00M) | $62.00M | $177.00M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 25.3% | 24.0% | 21.3% | 20.5% | 23.4% | 19.1% |
| Operating margin | 16.7% | 15.4% | 13.4% | 9.0% | 13.3% | 0.8% |
| EBITDA margin | 20.9% | 19.2% | 17.0% | 12.4% | 18.0% | 6.8% |
| Net margin | 8.9% | 9.5% | 11.3% | 4.8% | 7.3% | -9.1% |
| Free cash flow margin | 10.5% | 11.3% | 8.9% | -2.6% | 1.8% | 6.8% |
| FCF / Net income | 1.18 | 1.19 | 0.79 | -0.53 | 0.25 | -0.74 |
| R&D / Revenue | 1.6% | 1.6% | 1.5% | 1.3% | 1.6% | 2.2% |
| SG&A / Revenue | 7.0% | 7.1% | 6.4% | 6.0% | 8.5% | 11.2% |
| Effective tax rate | 37.2% | 22.6% | -6.7% | 32.8% | 33.0% | - |
| Return on assets | 8.7% | 10.2% | 12.3% | 5.9% | 7.6% | -8.6% |
| Return on equity | 21.4% | 26.7% | 35.2% | 23.3% | 26.4% | -34.4% |
| Return on invested capital | 16.2% | 18.9% | 22.3% | 13.2% | 18.3% | 0.9% |
| Liquidity | ||||||
| Current ratio | 1.61 | 2.08 | 1.98 | 1.65 | 1.24 | 1.85 |
| Quick ratio | 1.08 | 1.36 | 1.27 | 1.05 | 0.79 | 1.17 |
| Cash ratio | 0.27 | 0.29 | 0.29 | 0.19 | 0.15 | 0.29 |
| Leverage | ||||||
| Debt / Equity | 0.55 | 0.76 | 0.87 | 1.21 | 0.76 | 1.58 |
| Debt / Assets | 0.22 | 0.29 | 0.30 | 0.31 | 0.22 | 0.39 |
| Debt / EBITDA | 1.10 | 1.42 | 1.63 | 2.04 | 1.17 | 6.11 |
| Interest coverage | 8.2x | 7.6x | 5.8x | 6.9x | 9.3x | 0.4x |
| Equity multiplier | 2.46 | 2.62 | 2.85 | 3.93 | 3.49 | 4.02 |
| Liabilities / Assets | - | - | - | - | - | - |
| Efficiency | ||||||
| Asset turnover | 0.97 | 1.07 | 1.09 | 1.23 | 1.03 | 0.94 |
| Inventory turnover | 5.50 | 5.50 | 5.29 | 5.17 | 4.99 | 5.89 |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | 66d | 66d | 69d | 71d | 73d | 62d |
| Days payable outstanding | 60d | 60d | 52d | 57d | 67d | 55d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 12.6x | 16.6x | 9.0x | 17.6x | 11.5x | - |
| P / B | 2.7x | 4.4x | 3.1x | 4.0x | 3.0x | 3.0x |
| P / S | 1.1x | 1.6x | 1.0x | 0.8x | 0.8x | 0.8x |
| EV / EBITDA | 6.1x | 9.3x | 7.1x | 8.4x | 5.5x | 16.7x |
| Growth | ||||||
| Revenue growth (YoY) | -7.0% | 1.6% | -9.0% | 26.8% | 30.4% | -21.7% |
| Revenue CAGR (3y) | -4.9% | 5.4% | 14.6% | 9.0% | 1.7% | -1.3% |
| Revenue CAGR (5y) | 7.3% | 3.7% | 3.9% | 9.7% | 7.2% | -1.9% |
| Gross profit growth (YoY) | -2.1% | 14.4% | -5.2% | 10.8% | 59.8% | -27.0% |
| Operating income growth (YoY) | 1.1% | 16.7% | 35.2% | -14.3% | 2061.9% | -93.1% |
| Net income growth (YoY) | -12.9% | -14.6% | 112.9% | -16.4% | - | - |
| EPS growth (YoY) | -10.4% | -13.1% | 113.5% | -16.6% | - | - |
| EPS CAGR (3y) | 18.5% | 15.7% | - | 11.2% | - | - |
| EPS CAGR (5y) | - | 20.6% | - | -1.0% | 13.0% | - |
| FCF growth (YoY) | -13.3% | 28.5% | - | - | -65.0% | 27.3% |
| FCF CAGR (5y) | 17.2% | 26.5% | 38.4% | - | -26.0% | -13.1% |
| Book value growth (YoY) | 8.8% | 12.7% | 40.8% | -5.2% | 37.0% | -30.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-09-30.
Business segments
$3.59B totalReinforcement Materials$2.34B · 65.2%
Performance Chemicals$1.25B · 34.8%
Product / service
$122.00M totalShipping And Handling$112.00M · 91.8%
Other Products And Services$10.00M · 8.2%
Geographic
$6.05B totalOther Foreign Countries$2.11B · 34.9%
Americas$944.00M · 15.6%
CN$931.00M · 15.4%
Asia Pacific$865.00M · 14.3%
US$670.00M · 11.1%
EMEA$532.00M · 8.8%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
6/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Miscellaneous Chemical Products
Comparing CABOT CORP against the 5 most active filers in the same SIC group.
Dividends
$1.82/share trailing 12 months · +4.8% YoY
| Ex-date | Per share |
|---|---|
| May 29, 2026 | $0.4730 |
| Feb 27, 2026 | $0.4500 |
| Nov 28, 2025 | $0.4500 |
| Aug 29, 2025 | $0.4500 |
| May 30, 2025 | $0.4500 |
| Feb 28, 2025 | $0.4300 |
| Nov 29, 2024 | $0.4300 |
| Aug 30, 2024 | $0.4300 |
| May 31, 2024 | $0.4300 |
| Feb 22, 2024 | $0.4000 |
| Nov 22, 2023 | $0.4000 |
| Aug 24, 2023 | $0.4000 |
| May 25, 2023 | $0.4000 |
| Feb 23, 2023 | $0.3700 |
| Nov 23, 2022 | $0.3700 |
| Aug 25, 2022 | $0.3700 |
| May 26, 2022 | $0.3700 |
| Feb 24, 2022 | $0.3700 |
| Nov 24, 2021 | $0.3700 |
| Aug 26, 2021 | $0.3500 |
| May 27, 2021 | $0.3500 |
| Feb 25, 2021 | $0.3500 |
| Nov 25, 2020 | $0.3500 |
| Aug 27, 2020 | $0.3500 |